Urologix, Inc. (ULGX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 8, 2026
Urologix Market Cap
Urologix has a market cap or net worth of $2.13 thousand as of January 16, 2026. Its market cap has decreased by -98.67% in one year.
Market Cap
2.13K
Enterprise Value
n/a
Revenue
12.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 30, 1996, Urologix's market cap has decreased from 18.27M to 2.13K, a decrease of -99.99%. That is a compound annual growth rate of -26.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 2.13K | - |
| Dec 29, 2025 | 2.13K | - |
| Dec 20, 2024 | 2.13K | 10,033.33% |
| Dec 20, 2023 | 21.00 | -99.01% |
| Dec 30, 2022 | 2.13K | 10,033.33% |
| Dec 31, 2021 | 21.00 | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 811.81M |
| Glass House Brands | 738.79M |
| Elite Pharmaceuticals | 515.71M |
| Northwest Biotherapeutics | 440.23M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 338.88M |
| Silence Therapeutics | 277.26M |